Manan Desai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Manan Desai has a total of 134 co-authors. Here are the top co-authors by number of shared publications:
Aybala Tongut
9 shared publications- Can Yerebakan
Nationwide Children's Hospital
9 shared publications Can Yerebakan
7 shared publicationsSyed Bukhari
Department of Cardiovascular Surgery, Children's National Hospital, Washington, DC, USA
4 shared publicationsAmber Malhotra
Departments of Cardiovascular and Thoracic Surgery, Asarwa, Ahmedabad, India
3 shared publications- Karthik Ramakrishnan
Division of Pediatric Cardiac Surgery, Penn State Health Children's Hospital, Hershey, PA, USA
3 shared publications
Latest Publications
- Open Access
- 28 August 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (9)
Outcomes of Delayed Norwood Operation in High-Risk Patients—Time to Reconsider the Dogma of a Primary Norwood Operation?
Objectives: The delayed Norwood (DN) approach, preceded by bilateral pulmonary artery banding (bPAB), has emerged as a strategy to improve outcomes in high-risk infants by addressing neonatal haemodynamic instability and organ immaturity. Methods: This single-centre, retrospective study analysed 20 consecutive patients with hypoplastic left heart syndrome/variants and multiple risk factors who underwent a DN operation following bPAB between 2019 and 2024. Results: Bilateral pulmonary artery banding was performed at a median age of 2.5 days (interquartile range [IQR]: 2-4). Preoperative risk factors included prematurity (35%), low birth weight <2.5 kg (25%), non-cardiac comorbidities (25%), genetic syndromes (50%), preoperative cardiogenic shock (35%), and restrictive atrial septum (25%). The median age at DN was 36 days (IQR: 29-79), with an operative survival rate of 75%. Patients who underwent the DN within 4 weeks of bPAB did not require any pulmonary artery (PA) reinterventions. Median lactate clearance time was 8 hours (IQR: 5-18), and the median vasoactive inotropic score decreased by 47% within 48 hours postoperatively. Cerebral near-infrared spectroscopy values improved in patients without postoperative extracorporeal membrane oxygenation (ECMO) support from 53% to 58% and 63% at 0, 12, and 36 hours, respectively. Conclusions: The DN approach, preceded by initial bPAB in a high-risk patient cohort, achieved surgical outcomes comparable to those of lower-risk patients undergoing primary Norwood operation. A DN procedure around 4-6 weeks of following bPAB may improve survival rates in high-risk patients with a reduction in surgical or catheter-based reinterventions.
- 28 August 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (9)
Open AccessOutcomes of Delayed Norwood Operation in High-Risk Patients—Time to Reconsider the Dogma of a Primary Norwood Operation?
Objectives: The delayed Norwood (DN) approach, preceded by bilateral pulmonary artery banding (bPAB), has emerged as a strategy to improve outcomes in high-risk infants by addressing neonatal haemodynamic instability and organ immaturity. Methods: This single-centre, retrospective study analysed 20 consecutive patients with hypoplastic left heart syndrome/variants and multiple risk factors who underwent a DN operation following bPAB between 2019 and 2024. Results: Bilateral pulmonary artery banding was performed at a median age of 2.5 days (interquartile range [IQR]: 2-4). Preoperative risk factors included prematurity (35%), low birth weight <2.5 kg (25%), non-cardiac comorbidities (25%), genetic syndromes (50%), preoperative cardiogenic shock (35%), and restrictive atrial septum (25%). The median age at DN was 36 days (IQR: 29-79), with an operative survival rate of 75%. Patients who underwent the DN within 4 weeks of bPAB did not require any pulmonary artery (PA) reinterventions. Median lactate clearance time was 8 hours (IQR: 5-18), and the median vasoactive inotropic score decreased by 47% within 48 hours postoperatively. Cerebral near-infrared spectroscopy values improved in patients without postoperative extracorporeal membrane oxygenation (ECMO) support from 53% to 58% and 63% at 0, 12, and 36 hours, respectively. Conclusions: The DN approach, preceded by initial bPAB in a high-risk patient cohort, achieved surgical outcomes comparable to those of lower-risk patients undergoing primary Norwood operation. A DN procedure around 4-6 weeks of following bPAB may improve survival rates in high-risk patients with a reduction in surgical or catheter-based reinterventions.
- Open Access
- 1 July 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (7)
Neonatal primary repair of pulmonary atresia with ventricular septal defect without major aortopulmonary collateral arteries: midterm outcomes
OBJECTIVES: Pulmonary atresia with ventricular septal defect (PA-VSD) without major aortopulmonary collateral arteries is a rare congenital heart defect. Surgical management strategies include staged palliation or primary neonatal repair. We evaluated the midterm outcomes of neonatal primary repair in patients without MAPCAs. METHODS: A retrospective single-center analysis was performed of 31 neonates who underwent primary repair for PA-VSD without MAPCAs between 2005 and 2024. Primary outcomes included mortality, reintervention rates, and right ventricular (RV) function. RESULTS: Thirteen patients (41.9%) underwent urgent surgery and 18 (58.1%) underwent emergent surgery. Median weight at repair was 2.8 kg (interquartile range [IQR] 2.6–3.2). Overall survival was 96.8% (n = 30), with one mortality (3.2%) related to multi-organ failure. Postoperative RV function was normal in 25 patients (80.7%). Median follow-up for hospital survivors was 5.4 years (IQR 1.2–7.6). Freedom from surgical reoperation was 56.7%; 13 patients (43.3%) required reoperation, most commonly for RV-to-pulmonary artery conduit revision (n = 11). Catheter-based reinterventions were performed in 24 patients (80.0%). RV function remained preserved in 29 patients (96.7%) at last follow-up. CONCLUSIONS: Neonatal primary repair of PA-VSD without major aortopulmonary collaterals can be performed with excellent midterm survival and preserved right ventricular function. Reintervention, largely conduit-related, represents an anticipated component of longitudinal management rather than failure of the primary strategy.
- 1 July 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (7)
Open AccessNeonatal primary repair of pulmonary atresia with ventricular septal defect without major aortopulmonary collateral arteries: midterm outcomes
OBJECTIVES: Pulmonary atresia with ventricular septal defect (PA-VSD) without major aortopulmonary collateral arteries is a rare congenital heart defect. Surgical management strategies include staged palliation or primary neonatal repair. We evaluated the midterm outcomes of neonatal primary repair in patients without MAPCAs. METHODS: A retrospective single-center analysis was performed of 31 neonates who underwent primary repair for PA-VSD without MAPCAs between 2005 and 2024. Primary outcomes included mortality, reintervention rates, and right ventricular (RV) function. RESULTS: Thirteen patients (41.9%) underwent urgent surgery and 18 (58.1%) underwent emergent surgery. Median weight at repair was 2.8 kg (interquartile range [IQR] 2.6–3.2). Overall survival was 96.8% (n = 30), with one mortality (3.2%) related to multi-organ failure. Postoperative RV function was normal in 25 patients (80.7%). Median follow-up for hospital survivors was 5.4 years (IQR 1.2–7.6). Freedom from surgical reoperation was 56.7%; 13 patients (43.3%) required reoperation, most commonly for RV-to-pulmonary artery conduit revision (n = 11). Catheter-based reinterventions were performed in 24 patients (80.0%). RV function remained preserved in 29 patients (96.7%) at last follow-up. CONCLUSIONS: Neonatal primary repair of PA-VSD without major aortopulmonary collaterals can be performed with excellent midterm survival and preserved right ventricular function. Reintervention, largely conduit-related, represents an anticipated component of longitudinal management rather than failure of the primary strategy.
- Open Access
- 23 June 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (6) , e70374
Comparing Outcomes of Heartmate 3 and Heart Transplantation in Older Children With Dilated Cardiomyopathy—Can Transplantation be Delayed or Avoided?
Background: Children with end‐stage dilated cardiomyopathy (DCM) usually undergo heart transplantation or a short‐term bridge with a ventricular assist device. Heartmate 3 (HM3) may represent an appealing longer‐term option, though pediatric data are limited. We analyzed two clinical registries and hypothesized that adolescents with DCM treated with either HM3 or transplant would present similar survival. Methods: The Pedimacs and Pediatric Heart Transplant Society registries were queried for DCM patients ages 10–18 years treated with HM3 or transplant, between 2017 and 2022. Mortality and adverse events were reported. Results: Ninety HM3 and 306 transplant patients were reported within the respective registries. There was a higher proportion of Black patients in the HM3 cohort (40% vs. 30% in the transplant cohort, p = 0.03). Twelve‐ and 36‐month survival rates were both 94.4% for HM3 patients and were 99.3% and 95.6% for transplant patients. In the HM3 group, there were 66 transplants (median time of 2.8 months), 3 late explants for recovery, and 3 early deaths. Conditional 1‐year survival for HM3 and transplant was 100% and 96.3%, respectively, at 3 years. In the HM3 group, bleeding, stroke, and device malfunction rates were low at 0.1 events per patient per year. Conclusions: Adolescents with DCM treated with either HM3 or transplant had excellent 3‐year outcomes, though many HM3 pediatric patients are transplanted early after device placement. Safely supporting this group of patients for an extended duration with HM3 has implications for delaying/avoiding transplantation, longer‐term patient survival, and donor organ availability.
- 23 June 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (6) , e70374
Open AccessComparing Outcomes of Heartmate 3 and Heart Transplantation in Older Children With Dilated Cardiomyopathy—Can Transplantation be Delayed or Avoided?
Background: Children with end‐stage dilated cardiomyopathy (DCM) usually undergo heart transplantation or a short‐term bridge with a ventricular assist device. Heartmate 3 (HM3) may represent an appealing longer‐term option, though pediatric data are limited. We analyzed two clinical registries and hypothesized that adolescents with DCM treated with either HM3 or transplant would present similar survival. Methods: The Pedimacs and Pediatric Heart Transplant Society registries were queried for DCM patients ages 10–18 years treated with HM3 or transplant, between 2017 and 2022. Mortality and adverse events were reported. Results: Ninety HM3 and 306 transplant patients were reported within the respective registries. There was a higher proportion of Black patients in the HM3 cohort (40% vs. 30% in the transplant cohort, p = 0.03). Twelve‐ and 36‐month survival rates were both 94.4% for HM3 patients and were 99.3% and 95.6% for transplant patients. In the HM3 group, there were 66 transplants (median time of 2.8 months), 3 late explants for recovery, and 3 early deaths. Conditional 1‐year survival for HM3 and transplant was 100% and 96.3%, respectively, at 3 years. In the HM3 group, bleeding, stroke, and device malfunction rates were low at 0.1 events per patient per year. Conclusions: Adolescents with DCM treated with either HM3 or transplant had excellent 3‐year outcomes, though many HM3 pediatric patients are transplanted early after device placement. Safely supporting this group of patients for an extended duration with HM3 has implications for delaying/avoiding transplantation, longer‐term patient survival, and donor organ availability.
- Open Access
- 5 May 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (5)
Injection Laryngoplasty as a Means of Resolving Symptomatic Vocal Cord Immobility After Congenital Heart Surgery
Objectives: Vocal cord immobility immediately following cardiac surgery is associated with reduced airway protection, dysphagia and aspiration in infant and paediatric populations. Early vocal medialization shows promise in optimizing feeding outcomes and swallowing mechanics. We aim to demonstrate the outcomes of injection laryngoplasty in patients with symptomatic vocal cord immobility after paediatric cardiac surgery. Methods: Data from cardiac surgery patients who underwent injection laryngoplasty between January 2021 and December 2024 at a single-centre institution were reviewed. Data was analysed following the implementation of a vocal cord injury protocol, including laryngeal ultrasound screening, preoperative dysphagia assessment, injection laryngoplasty and postoperative dysphagia evaluation as medically appropriate. Results: Thirty-one patients underwent injection laryngoplasty after diagnosis of symptomatic unilateral vocal cord immobility with objectively identified dysphagia a median of 10 days (2-63) after surgery. A postoperative endoscopic or fluoroscopic swallow study was conducted with dysphagia improving or resolving in 26 of 31 patients post-injection. Four patients were discharged with gastrostomy tubes. Seven patients had a documented complication, including stridor, escalation of care setting, and additional required procedures. These were short-lived and often associated with underlying congenital heart disease and unrelated to vocal cord injection. Conclusions: Injection laryngoplasty as an intervention for vocal immobility and dysphagia following cardiovascular surgery is a low-risk procedure, allowing safer advancement of oral diet in most patients prior to discharge. We postulate it also improves dysphagia in the subacute phase and may lead to longer-term benefit in glottic protection.
- 5 May 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (5)
Open AccessInjection Laryngoplasty as a Means of Resolving Symptomatic Vocal Cord Immobility After Congenital Heart Surgery
Objectives: Vocal cord immobility immediately following cardiac surgery is associated with reduced airway protection, dysphagia and aspiration in infant and paediatric populations. Early vocal medialization shows promise in optimizing feeding outcomes and swallowing mechanics. We aim to demonstrate the outcomes of injection laryngoplasty in patients with symptomatic vocal cord immobility after paediatric cardiac surgery. Methods: Data from cardiac surgery patients who underwent injection laryngoplasty between January 2021 and December 2024 at a single-centre institution were reviewed. Data was analysed following the implementation of a vocal cord injury protocol, including laryngeal ultrasound screening, preoperative dysphagia assessment, injection laryngoplasty and postoperative dysphagia evaluation as medically appropriate. Results: Thirty-one patients underwent injection laryngoplasty after diagnosis of symptomatic unilateral vocal cord immobility with objectively identified dysphagia a median of 10 days (2-63) after surgery. A postoperative endoscopic or fluoroscopic swallow study was conducted with dysphagia improving or resolving in 26 of 31 patients post-injection. Four patients were discharged with gastrostomy tubes. Seven patients had a documented complication, including stridor, escalation of care setting, and additional required procedures. These were short-lived and often associated with underlying congenital heart disease and unrelated to vocal cord injection. Conclusions: Injection laryngoplasty as an intervention for vocal immobility and dysphagia following cardiovascular surgery is a low-risk procedure, allowing safer advancement of oral diet in most patients prior to discharge. We postulate it also improves dysphagia in the subacute phase and may lead to longer-term benefit in glottic protection.
- Open Access
- 30 September 2025
- Published by Aydin Pediatric Society in Trends in Pediatrics
- Vol. 6 (3) , 202-207
Is the patch repair of partial anomalous pulmonary venous drainage equivalent to the Warden procedure?
Introduction: Partial anomalous pulmonary venous return (PAPVR) is a congenital heart defect frequently associated with a sinus venosus atrial septal defect (ASD). Surgical repair varies depending on the anatomical position of the anomalous pulmonary veins. This study aims to compare the outcomes of three surgical techniques - single patch, two-patch technique, and Warden procedure- used in the repair of PAPVR with sinus venosus ASD. Methods: A retrospective study was conducted, analyzing the outcomes of 87 patients who underwent surgical repair for PAPVR between January 2011 and August 2024. Patients were divided into three groups based on the surgical technique used: 44 underwent the Warden procedure, 33 were treated with the single-patch technique, and 10 received the two-patch technique. Results: No mortality was observed across all techniques. The median age at operation was 5.4 years (1.4–10.4 years), and the median hospital stay was 3.0 days (IQR 3.0–4.0). Logistic regression analysis revealed a higher likelihood of immediate postoperative complications with the Warden technique (OR: 5.00, 95% CI [1.30–19.25], p = 0.0193). No patients required a pacemaker implantation. Four patients who had a single (2) and double patch (2) technique needed a reintervention on the systemic or pulmonary venous pathway, while no patient who had a Warden procedure needed a reintervention of the venous pathways. Conclusion: Despite a higher risk of early complications, the Warden procedure seems to preserve patients from reinterventions on the systemic or pulmonary venous pathway.
- 30 September 2025
- Published by Aydin Pediatric Society in Trends in Pediatrics
- Vol. 6 (3) , 202-207
Open AccessIs the patch repair of partial anomalous pulmonary venous drainage equivalent to the Warden procedure?
Introduction: Partial anomalous pulmonary venous return (PAPVR) is a congenital heart defect frequently associated with a sinus venosus atrial septal defect (ASD). Surgical repair varies depending on the anatomical position of the anomalous pulmonary veins. This study aims to compare the outcomes of three surgical techniques - single patch, two-patch technique, and Warden procedure- used in the repair of PAPVR with sinus venosus ASD. Methods: A retrospective study was conducted, analyzing the outcomes of 87 patients who underwent surgical repair for PAPVR between January 2011 and August 2024. Patients were divided into three groups based on the surgical technique used: 44 underwent the Warden procedure, 33 were treated with the single-patch technique, and 10 received the two-patch technique. Results: No mortality was observed across all techniques. The median age at operation was 5.4 years (1.4–10.4 years), and the median hospital stay was 3.0 days (IQR 3.0–4.0). Logistic regression analysis revealed a higher likelihood of immediate postoperative complications with the Warden technique (OR: 5.00, 95% CI [1.30–19.25], p = 0.0193). No patients required a pacemaker implantation. Four patients who had a single (2) and double patch (2) technique needed a reintervention on the systemic or pulmonary venous pathway, while no patient who had a Warden procedure needed a reintervention of the venous pathways. Conclusion: Despite a higher risk of early complications, the Warden procedure seems to preserve patients from reinterventions on the systemic or pulmonary venous pathway.
- 3 May 2025
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 41 (6) , 745-755
The single ventricle presenting late: surgical options
The term single ventricle (SV) comprises a wide variety of congenital anomalies with a structurally or functionally univentricular heart where a biventricular repair is not possible or undesirable. The surgical management of these patients is often staged and the ultimate palliation is the Fontan operation (FO). Despite advances in surgical techniques, significant challenges persist in the management of SV patients, particularly in low- and middle-income countries (LMICs), where delayed presentation and limited healthcare access are common. This review explores current management strategies for patients beyond childhood, including those who have never undergone palliation and post-Fontan patients facing long-term complications. Key topics include the surgical approaches to SV, such as pulmonary artery banding (PAB), bidirectional Glenn (BDG), and FO, with particular focus on considerations for late-presenting adults in LMICs. The disparities in healthcare resources between high-income countries and LMICs are highlighted, demonstrating that resource constraints significantly impact timely interventions and on-going follow-up care.
- 3 May 2025
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 41 (6) , 745-755
The single ventricle presenting late: surgical options
The term single ventricle (SV) comprises a wide variety of congenital anomalies with a structurally or functionally univentricular heart where a biventricular repair is not possible or undesirable. The surgical management of these patients is often staged and the ultimate palliation is the Fontan operation (FO). Despite advances in surgical techniques, significant challenges persist in the management of SV patients, particularly in low- and middle-income countries (LMICs), where delayed presentation and limited healthcare access are common. This review explores current management strategies for patients beyond childhood, including those who have never undergone palliation and post-Fontan patients facing long-term complications. Key topics include the surgical approaches to SV, such as pulmonary artery banding (PAB), bidirectional Glenn (BDG), and FO, with particular focus on considerations for late-presenting adults in LMICs. The disparities in healthcare resources between high-income countries and LMICs are highlighted, demonstrating that resource constraints significantly impact timely interventions and on-going follow-up care.
- 21 February 2025
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 16 (2) , 227-231
Rehabilitation Strategy Should Not Be a Pretext for Suboptimal Repair for Pulmonary Atresia, Ventricular Septal Defect, and Major Aortopulmonary Collateral Arteries
Pulmonary atresia, ventricular septal defect, and major aortopulmonary collaterals are a challenging congenital anomaly to manage surgically with different centers and strategies producing wide-ranging outcomes. Over the past few decades despite diverging treatment pathways, there is an emerging consensus of how these patients “should” be treated. Quite often a combination of rehabilitation strategy and a unifocalization approach has to be tailored to each patient to address the anatomic and physiological variations that characterize this congenital heart defect. Irrespective of the surgical approach, the goal should be to have a complete repair with acceptable right heart pressure ensuring survival and a good quality of life.
- 21 February 2025
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 16 (2) , 227-231
Rehabilitation Strategy Should Not Be a Pretext for Suboptimal Repair for Pulmonary Atresia, Ventricular Septal Defect, and Major Aortopulmonary Collateral Arteries
Pulmonary atresia, ventricular septal defect, and major aortopulmonary collaterals are a challenging congenital anomaly to manage surgically with different centers and strategies producing wide-ranging outcomes. Over the past few decades despite diverging treatment pathways, there is an emerging consensus of how these patients “should” be treated. Quite often a combination of rehabilitation strategy and a unifocalization approach has to be tailored to each patient to address the anatomic and physiological variations that characterize this congenital heart defect. Irrespective of the surgical approach, the goal should be to have a complete repair with acceptable right heart pressure ensuring survival and a good quality of life.
- 30 January 2024
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 15 (4) , 446-452
Real-Time Detection of Circulating Thrombi in an Extracorporeal Circuit Using Doppler Ultrasound: In-Vitro Proof of Concept Study
Background: Thromboembolic stroke continues to be by far the most common severe adverse event in patients supported with mechanical circulatory assist devices. Feasibility of using Doppler ultrasound to detect circulating thrombi in an extracorporeal circuit was investigated. Methods: A mock extracorporeal circulatory loop of uncoated cardiopulmonary bypass tubing and a roller pump was setup. A Doppler bubble counter was used to monitor the mean ultrasound backscatter signal (MUBS). The study involved two sets of experiments. In Scenario 1, the circuit was sequentially primed with human blood components, and the MUBS was measured. In Scenario 2, the circuit was primed with heparinized fresh porcine blood, and the MUBS was measured. Fresh blood clots (diameter 5,000 microns) were injected into the circuit followed by protamine administration. Results: In Scenario 1 (n = 3), human platelets produced a baseline MUBS of 1.5 to 3.5 volts/s. Addition of packed human red blood cells increased the baseline backscatter to 17 to 21 volts/s. Addition of fresh frozen plasma did not change the baseline backscatter. In Scenario 2 (n = 5), the blood-primed circuit produced a steady baseline MUBS. Injection of the clots resulted in abrupt and transient increase (range: 3-30 volts/s) of the baseline MUBS. Protamine administration resulted in a sustained increase of MUBS followed by circuit thrombosis. Conclusions: Doppler ultrasound may be used for real-time detection of circulating solid microemboli in the extracorporeal circuit. This technology could potentially be used to design safety systems that can reduce the risk of thromboembolic stroke associated with mechanical circulatory support therapy.
- 30 January 2024
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 15 (4) , 446-452
Real-Time Detection of Circulating Thrombi in an Extracorporeal Circuit Using Doppler Ultrasound: In-Vitro Proof of Concept Study
Background: Thromboembolic stroke continues to be by far the most common severe adverse event in patients supported with mechanical circulatory assist devices. Feasibility of using Doppler ultrasound to detect circulating thrombi in an extracorporeal circuit was investigated. Methods: A mock extracorporeal circulatory loop of uncoated cardiopulmonary bypass tubing and a roller pump was setup. A Doppler bubble counter was used to monitor the mean ultrasound backscatter signal (MUBS). The study involved two sets of experiments. In Scenario 1, the circuit was sequentially primed with human blood components, and the MUBS was measured. In Scenario 2, the circuit was primed with heparinized fresh porcine blood, and the MUBS was measured. Fresh blood clots (diameter 5,000 microns) were injected into the circuit followed by protamine administration. Results: In Scenario 1 (n = 3), human platelets produced a baseline MUBS of 1.5 to 3.5 volts/s. Addition of packed human red blood cells increased the baseline backscatter to 17 to 21 volts/s. Addition of fresh frozen plasma did not change the baseline backscatter. In Scenario 2 (n = 5), the blood-primed circuit produced a steady baseline MUBS. Injection of the clots resulted in abrupt and transient increase (range: 3-30 volts/s) of the baseline MUBS. Protamine administration resulted in a sustained increase of MUBS followed by circuit thrombosis. Conclusions: Doppler ultrasound may be used for real-time detection of circulating solid microemboli in the extracorporeal circuit. This technology could potentially be used to design safety systems that can reduce the risk of thromboembolic stroke associated with mechanical circulatory support therapy.